ArtiQ is a young, dynamic and innovative spin-off company of the University of Leuven (Belgium). The company was founded early 2019 by four committed founders with an extensive history in respiratory medicine, medical devices, and artificial intelligence.
From their multidisciplinary backgrounds and five years of research, the founders identified the value that novel technologies could bring to all parties in the respiratory world: patients, doctors, healthcare systems, and the industry. ArtiQ empowers medical professionals with artificial intelligence to accurately and timely diagnose, treat and follow-up patients with lung diseases.
With our first artificial intelligence-based software, ArtiQ.PFT, we support the interpretation of pulmonary function tests and improve the diagnostic environment for respiratory diseases. The software has been validated elaborately at UZ Leuven, where it is used to create a report for every patient. ArtiQ.PFT has been used for over 61 774 interpretations since the first implementation in February 2018.